CDC-RFA-PW-26-2600: Preventive Health and Health Services Block Grant – 2026
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Centers for Disease Control-PHIC notices from 2026.
Centers for Disease Control-PHIC offered grants to state and local governments and tribes. It expected to make about 61 awards worth $156 million in total. Applications closed on July 17, 2026.
From the official notice on Grants.gov, last changed July 13, 2026. Checked November 7, 2026.
- Total funding$156 million
- Expected awards61
- Cost sharingNot required
- Funding typeGrant
Key dates
| Posted | May 27, 2026 |
|---|---|
| Deadline | July 17, 2026 |
| Archived by Grants.gov | August 16, 2026 |
Who can apply
This opportunity was open to state and local governments and tribes.
- State governments
- Native American tribal governments (Federally recognized)
This program provides funding to the 61 eligible applicants identified in the authorizing statute to address their unique public health needs and challenges using innovative, locally defined methods. All 50 U.S. states (State Health Departments), the District of Columbia, 2 American Indian Tribes (Santee Sioux; Kickapoo Tribe, KS), 5 U.S. Territories (American Samoa, Guam, Commonwealth of Northern Mariana Islands, Puerto Rico, U.S. Virgin Islands) and 3 Freely Associated States (Federated States of Micronesia, Republic of Marshall Islands, and Republic of Palau) are eligible to apply.
Is this a realistic fit?
- Most of the program's money (96% over five years) went to state and local governments.
- No cost sharing or match is required.
What the grant funds
The PHHS Block Grant Program allows recipients to address their own unique public health needs and challenges with evidence-based, innovative and community-driven methods. Recipients set their own goals and program objectives to address local priorities.
Who has won Preventive Health and Health Services Block Grant grants before
From fiscal 2021 to 2025, Preventive Health and Health Services Block Grant (93.991) awarded $721 million across 303 grant awards, an average of $2.4 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| NYS Department of Health | New York | 5 | $56.1 million |
| California Department of Public Health | California | 5 | $54.1 million |
| Pennsylvania Department of Health | Pennsylvania | 5 | $39.0 million |
| Ohio Department of Health | Ohio | 5 | $36.0 million |
| Department of State Health Services | Texas | 5 | $33.2 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is CDC-RFA-PW-26-2600 still open?
No. It closed on July 17, 2026.
Who can apply for Preventive Health and Health Services Block Grant – 2026?
Centers for Disease Control-PHIC accepted applications from state and local governments and tribes. The notice adds further conditions, so read its eligibility section.
What is the deadline for Preventive Health and Health Services Block Grant – 2026?
Closed July 17, 2026. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
About $156 million in total across about 61 awards.
Who has won Preventive Health and Health Services Block Grant grants before?
The largest recipients over five fiscal years were NYS Department of Health, California Department of Public Health, Pennsylvania Department of Health. The program made 303 awards worth $721 million in that time.
Similar open grants
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
- Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)
- Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)